SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001576885-24-000067
Filing Date
2024-06-05
Accepted
2024-06-05 16:36:13
Documents
13
Period of Report
2024-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K abos-20240604.htm   iXBRL 8-K 31768
  Complete submission text file 0001576885-24-000067.txt   158731

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abos-20240604.xsd EX-101.SCH 1901
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abos-20240604_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abos-20240604_pre.xml EX-101.PRE 13043
16 EXTRACTED XBRL INSTANCE DOCUMENT abos-20240604_htm.xml XML 2809
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40551 | Film No.: 241022481
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)